Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current developments on sickle cell disease].

R Girot1

  • 1Hôpital Tenon, Paris.

Revue Medicale De Bruxelles
|February 4, 2006
PubMed
Summary
This summary is machine-generated.

Sickle cell disease is a genetic blood disorder caused by a mutation in the beta-globin gene, leading to abnormal hemoglobin S. Improved treatments have increased life expectancy for patients with this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study.

The British journal of dermatology·2016
Same author

Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2016
Same author

Maternal mortality among women with sickle-cell disease in France, 1996-2009.

European journal of obstetrics, gynecology, and reproductive biology·2015
Same author

Facial lesions heralding the onset and relapse of eosinophilic fasciitis.

Clinical and experimental dermatology·2015
Same author

[The impact of screening sickle-cell carriers in the general population. A retrospective study in the Paris screening center].

Revue d'epidemiologie et de sante publique·2015
Same author

Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity.

Journal of allergy·2011

Area of Science:

  • Genetics
  • Hematology
  • Molecular Biology

Context:

  • Sickle cell disease (SCD) is an inherited autosomal recessive blood disorder.
  • It stems from a specific mutation in the beta-globin gene, producing abnormal hemoglobin S (HbS).
  • Global population movements have led to SCD spreading worldwide.

Purpose:

  • To describe the pathophysiology, global distribution, complications, and current treatment landscape of sickle cell disease.
  • To highlight recent advancements in patient care and life expectancy.

Summary:

  • SCD involves HbS polymerization, causing chronic hemolytic anemia and vaso-occlusive events.
  • Common complications in children include painful crises, severe infections, and neurological events.
  • Life expectancy has improved, now exceeding 40 years with advancements in care.

Related Experiment Videos

Impact:

  • Recent therapeutic progress has significantly improved the prognosis for sickle cell disease patients.
  • Conventional treatments include antibiotics, immunizations, analgesics, and blood transfusions.
  • Ongoing research compares the efficacy of chronic blood transfusions, hydroxyurea, and bone marrow transplantation.